EZH2 and triple-negative breast carcinoma: EZH2, a driver of invasiveness in multiple cancer types, upregulates KRT14 through the H3K27me3 mechanism to enhance peritoneal metastasis in triple-negative breast cancer (TNBC), suggesting that targeted inhibition of EZH2 could potentially impede TNBC metastasis [42].